Get started
Actinogen Med Ltd.Actinogen Med Ltd.Actinogen Med Ltd.

Actinogen Med Ltd.

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonals

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪103.06 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0032 USD
Net income (FY)
‪−9.69 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪2.88 B‬
Beta (1Y)
−0.14

About Actinogen Medical Limited


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Steven G. Gourlay
Website
actinogen.com.au
Headquarters
Sydney
Founded
1999
IPO date
Oct 16, 2007
Identifiers
2
ISIN AU000000ACW3
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company was founded by Geoff E. D. Brooke & David Keast on March 23, 1999 and is headquartered in Sydney, Australia.

Check out other big names from the same industry as ATGGF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ATGGF is 0.0311 USD — it has decreased by −22.25% in the past 24 hours. Watch Actinogen Med Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Actinogen Med Ltd. stocks are traded under the ticker ATGGF.
We've gathered analysts' opinions on Actinogen Med Ltd. future price: according to them, ATGGF price has a max estimate of 0.06 USD and a min estimate of 0.06 USD. Watch ATGGF chart and read a more detailed Actinogen Med Ltd. stock forecast: see what analysts think of Actinogen Med Ltd. and suggest that you do with its stocks.
ATGGF reached its all-time high on Jan 9, 2023 with the price of 0.1000 USD, and its all-time low was 0.0100 USD and was reached on Aug 9, 2019. View more price dynamics on ATGGF chart.
See other stocks reaching their highest and lowest prices.
ATGGF stock is 28.62% volatile and has beta coefficient of −0.14. Track Actinogen Med Ltd. stock price on the chart and check out the list of the most volatile stocks — is Actinogen Med Ltd. there?
Today Actinogen Med Ltd. has the market capitalization of ‪103.06 M‬, it has decreased by −9.38% over the last week.
Yes, you can track Actinogen Med Ltd. financials in yearly and quarterly reports right on TradingView.
Actinogen Med Ltd. is going to release the next earnings report on Feb 19, 2026. Keep track of upcoming events with our Earnings Calendar.
ATGGF net income for the last half-year is ‪−4.32 M‬ USD, while the previous report showed ‪−5.05 M‬ USD of net income which accounts for 14.60% change. Track more Actinogen Med Ltd. financial stats to get the full picture.
No, ATGGF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ATGGF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Actinogen Med Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Actinogen Med Ltd. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Actinogen Med Ltd. stock shows the sell signal. See more of Actinogen Med Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.